The Alzheimer’s & Parkinson’s Drug Development Summit takes place in Boston, US on February 3-5. The meeting brings together experts in neurodegenerative diseases sharing insights from early discovery to late clinical development.
With long experience in supporting pharma clients in drug discovery for neurodegenerative diseases, for example in proteopathy-focused target and lead discovery, Cellectricon is looking forward to taking part in the meeting. If you are interested in learning more about Cellectricon’s neuroscience drug discovery services, reach out to setup a meeting with Paul Karila, our CBO, while in Boston.
Paul Karila
CBO
Meet us at the Alzheimer’s & Parkinson’s Drug Development Summit!
We are looking forward to taking part in this year’s meeting and for the opportunity to introduce our drug discovery services to prospective new partners. Get in touch if you are interested in setting up a meeting!